EPIX ESSA Pharma Inc: Nilai Akuntansi saben Saham

How sustainable is the financial position of ESSA Pharma Inc. (EPIX)? This chart provided by GURU.Markets shows that the book value per share currently stands at 2.46. Stability is underpinned by a lack of debt and a liquid reserve. Growth is driven by mazofotenan trials and interest from corporate behemoths. The development of treatments for resistant forms of prostate cancer confirms an active business expansion stage.

ESSA Pharma Inc (EPIX) - Nilai Akuntansi saben Saham saka 04.07.2022 nganti 25.10.2025

Ringkesan rincian data analitis ESSA Pharma, Inc. (EPIX)

- rega lan prakiraan konsensus rega:

Rega saham ESSA Pharma Inc|EPIX - Target median analis

- data kapitalisasi pasar:

Biji pasar ESSA Pharma Inc.|EPIX - Nilai Bisnis

- data kapitalisasi buku:

Nilai Buku saben Saham ESSA Pharma|EPIX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku essapharma.com|EPIX - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas ESSA Pharma Inc.|EPIX - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal ESSA Pharma Inc|EPIX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ESSA Pharma Inc.

Analisis kabeh metrik perusahaan:essapharma.com, EPIX

For ESSA Pharma Inc. (EPIX), the development of prostate cancer therapy is associated with a high cash burn, making the calculated book value per share a key indicator of the business's financial cushion. This metric reflects the portion of net assets attributable to a single share, allowing for an assessment of the company's real intrinsic value regardless of market volatility and confirming the capital's resilience to inflation.

Analisis pesaing ESSA Pharma Inc.